Diane K. Newman, DNP ANP-BC FAAN ### 215481###Speaker @@@ Scott MacDiarmid ### 215277###Speaker @@@ Jennifer U. Miles-Thomas, MD ### 535582###Speaker @@@ Thomas Roth, PhD ### 535583###Speaker
Sunday, May 20, 2018
10:00 AM - 11:00 AM
ERLEADA™ (apalutamide) An androgen receptor inhibitor indicated for the treatment of patients with non-metastatic castration-resistant prostate cancer (CRPC)
